The retail division of CVS Health Corporation, CVS Pharmacy, recently announced that they will be pulling decongestants with phenylephrine from their shelves. As of February 2, 2021, the company plans to stop selling products containing the active ingredient due to safety concerns.
Phenylephrine is a commonly used decongestant. It is found in many over-the-counter (OTC) medications used to temporarily alleviate nasal and sinus congestion. However, this drug has been linked to numerous health risks.
Recent studies have indicated that long-term use of phenylephrine could lead to an increased risk of cardiovascular events such as stroke, irregular heart rhythm, and sudden death. CVS Pharmacy has decided to take precautions and remove any products containing this active ingredient off of their shelves.
CVS Pharmacy stated in an official statement that they will be replacing these products with alternative options containing different active ingredients. The pharmacy chain will even offer to exchange any unopened items for a healthier alternative.
Although this may sound like a long process, CVS Pharmacy claims they are “dedicated to providing customers with safe and effective OTC options.” The safety of their customers has become their top priority and they want to ensure that no one is exposed to any drug with potential health risks.
Therefore, CVS Pharmacy has decided to take the necessary precaution of removing decongestants containing phenylephrine from their shelves and offer safer options. This move reflects their commitment to providing customers with the best possible health care solutions.